Evaluation of the Ketogenic Potential of Different Diet Supplements

NCT02693106 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2020-03-25

Study results available
· View outcomes & findings →

Summary

Evaluate the capacity of different dietary supplements to increase ketone production in healthy adults.

Conditions

  • Healthy Adults

Interventions

DIETARY_SUPPLEMENT

Control

Visit corresponding to a standardize breakfast taken alone (control visit) followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENT

Leucine

Visit corresponding to a standardize breakfast with 5 g of leucine followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENT

Butyrate -

Visit corresponding to a standardize breakfast with 3.6 g of butyrate followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENT

Butyrate +

Visit corresponding to a standardize breakfast with 7.2 g of butyrate followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENT

Octanoate -

Visit corresponding to a standardize breakfast with 5 g of octanoate followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENT

Octanoate +

Visit corresponding to a standardize breakfast with 10 g of octanoate followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENT

Carnitine

Visit corresponding to a standardize breakfast with 1.95 g of carnitine followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENT

Butter fraction

Visit corresponding to a standardize breakfast with 65 g of butter fraction followed by a period of 4-hour with multiple blood sampling.

Sponsors & Collaborators

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Stephen Cunnane, PhD · Research Centre on Aging CSSS-IUGS - CIUSSS de l'Estrie - CHUS

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693106 on ClinicalTrials.gov